Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. / Ward, Daniel; Neumann, Anders; Hendel, Jakob W.; Riis, Lene Buhl; Tøttrup, Anders; Jess, Tine; Aalykke, Claus.

In: Scandinavian Journal of Gastroenterology, Vol. 57, No. 4, 2022, p. 457-464.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Ward, D, Neumann, A, Hendel, JW, Riis, LB, Tøttrup, A, Jess, T & Aalykke, C 2022, 'Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease', Scandinavian Journal of Gastroenterology, vol. 57, no. 4, pp. 457-464. https://doi.org/10.1080/00365521.2021.2022191

APA

Ward, D., Neumann, A., Hendel, J. W., Riis, L. B., Tøttrup, A., Jess, T., & Aalykke, C. (2022). Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 57(4), 457-464. https://doi.org/10.1080/00365521.2021.2022191

Vancouver

Ward D, Neumann A, Hendel JW, Riis LB, Tøttrup A, Jess T et al. Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 2022;57(4):457-464. https://doi.org/10.1080/00365521.2021.2022191

Author

Ward, Daniel ; Neumann, Anders ; Hendel, Jakob W. ; Riis, Lene Buhl ; Tøttrup, Anders ; Jess, Tine ; Aalykke, Claus. / Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease. In: Scandinavian Journal of Gastroenterology. 2022 ; Vol. 57, No. 4. pp. 457-464.

Bibtex

@article{ae7106ddc2e44815aa690ac22c0cb439,

title = "Danish Society for Gastroenterology and Hepatology{\textquoteright}s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease",

abstract = "Objectives: We aimed to produce clinical recommendations for colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases. Materials and methods: The Danish Society for Gastroenterology and Hepatology convened a committee to assess the literature on colorectal cancer in inflammatory bowel diseases and the effectiveness of colonoscopy surveillance, according to the Oxford Centre for Evidence Based Medicine levels of evidence. Results: Clinical recommendations for the colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases were produced. These guidelines cover the risk stratification, entry, and follow-up of patients in the colonoscopy programme, the choice of image-enhanced colonoscopy modality, the investigation and treatment of lesions, and the management of special patient populations in the colonoscopy programme. Conclusions: Colonoscopic surveillance of inflammatory bowel disease is thought to be associated with a decreased risk of colorectal cancer and colorectal cancer-related mortality. Further evidence regarding the effectiveness of colonoscopic surveillance will contribute to understanding its role in the management of inflammatory bowel diseases. The Danish Society for Gastroenterology and Hepatology clinical guideline will aid gastroenterologists in the risk stratification of patients with inflammatory bowel disease, and the management of colorectal lesions. Gastroenterologists must inform and support patients with inflammatory bowel disease to decide whether to participate in the colonoscopic surveillance programme.",

keywords = "colonoscopy, colorectal cancer, Inflammatory bowel disease, screening",

author = "Daniel Ward and Anders Neumann and Hendel, {Jakob W.} and Riis, {Lene Buhl} and Anders T{\o}ttrup and Tine Jess and Claus Aalykke",

note = "Publisher Copyright: {\textcopyright} 2021 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2022",

doi = "10.1080/00365521.2021.2022191",

language = "English",

volume = "57",

pages = "457--464",

journal = "Scandinavian Journal of Gastroenterology",

issn = "0036-5521",

publisher = "Taylor & Francis",

number = "4",

}

RIS

TY - JOUR

T1 - Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease

AU - Ward, Daniel

AU - Neumann, Anders

AU - Hendel, Jakob W.

AU - Riis, Lene Buhl

AU - Tøttrup, Anders

AU - Jess, Tine

AU - Aalykke, Claus

PY - 2022

Y1 - 2022

N2 - Objectives: We aimed to produce clinical recommendations for colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases. Materials and methods: The Danish Society for Gastroenterology and Hepatology convened a committee to assess the literature on colorectal cancer in inflammatory bowel diseases and the effectiveness of colonoscopy surveillance, according to the Oxford Centre for Evidence Based Medicine levels of evidence. Results: Clinical recommendations for the colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases were produced. These guidelines cover the risk stratification, entry, and follow-up of patients in the colonoscopy programme, the choice of image-enhanced colonoscopy modality, the investigation and treatment of lesions, and the management of special patient populations in the colonoscopy programme. Conclusions: Colonoscopic surveillance of inflammatory bowel disease is thought to be associated with a decreased risk of colorectal cancer and colorectal cancer-related mortality. Further evidence regarding the effectiveness of colonoscopic surveillance will contribute to understanding its role in the management of inflammatory bowel diseases. The Danish Society for Gastroenterology and Hepatology clinical guideline will aid gastroenterologists in the risk stratification of patients with inflammatory bowel disease, and the management of colorectal lesions. Gastroenterologists must inform and support patients with inflammatory bowel disease to decide whether to participate in the colonoscopic surveillance programme.

AB - Objectives: We aimed to produce clinical recommendations for colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases. Materials and methods: The Danish Society for Gastroenterology and Hepatology convened a committee to assess the literature on colorectal cancer in inflammatory bowel diseases and the effectiveness of colonoscopy surveillance, according to the Oxford Centre for Evidence Based Medicine levels of evidence. Results: Clinical recommendations for the colonoscopic surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseases were produced. These guidelines cover the risk stratification, entry, and follow-up of patients in the colonoscopy programme, the choice of image-enhanced colonoscopy modality, the investigation and treatment of lesions, and the management of special patient populations in the colonoscopy programme. Conclusions: Colonoscopic surveillance of inflammatory bowel disease is thought to be associated with a decreased risk of colorectal cancer and colorectal cancer-related mortality. Further evidence regarding the effectiveness of colonoscopic surveillance will contribute to understanding its role in the management of inflammatory bowel diseases. The Danish Society for Gastroenterology and Hepatology clinical guideline will aid gastroenterologists in the risk stratification of patients with inflammatory bowel disease, and the management of colorectal lesions. Gastroenterologists must inform and support patients with inflammatory bowel disease to decide whether to participate in the colonoscopic surveillance programme.

KW - colonoscopy

KW - colorectal cancer

KW - Inflammatory bowel disease

KW - screening

U2 - 10.1080/00365521.2021.2022191

DO - 10.1080/00365521.2021.2022191

M3 - Journal article

C2 - 34968157

AN - SCOPUS:85122071288

VL - 57

SP - 457

EP - 464

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 4

ER -

ID: 290255905